Krsnaa Diagnostics Q2 FY27: revenue up 31.5% to ₹271 Cr, net profit up 2.7% to ₹25 Cr
Results · Finvezto · 3 Nov 2026 · Krsnaa Diagnostics (KRSNAA)
Results Q2 FY27, ₹ Cr
| Q2 FY27 | ₹ Cr | QoQ | YoY |
|---|---|---|---|
| Revenue | 271 | - | +31.5% |
| Operating profit | 71 | - | +20.2% |
| Net profit | 25 | - | +2.7% |
| Operating margin | 26.2% | - | -2.5 pp |
| Net margin | 9.1% | - | -2.5 pp |
YoY is the company's own figure. QoQ shows where our quarterly series matches the filing.
Key points
- Revenue from operations grew 32% year-on-year to INR 271 crores in Q2 FY27, while H1 FY27 revenue reached INR 507 crores, up 27% year-on-year. Earnings call
- Q2 FY27 EBITDA before CSR and ESOP expenses was INR 72 crores with a 27% margin, compared to 29% in Q2 FY26 due to upfront costs for new projects. Earnings call
- Profit after tax for Q2 FY27 stood at INR 25 crores with a 9% margin, up 3% year-on-year, impacted by higher depreciation and finance costs. Earnings call
What to watch
- Management on cash-based revenue mix: By the end of FY '27, we expect our cash-based revenues to contribute almost 40% to 45% of the overall revenue mix, aggregating to approximately INR400 crores for the year, further strengthening cash flows and working capital efficiency.
- Management on rajasthan annualized potential: Yes, on an annualized basis, Rajasthan has the potential to deliver those numbers, and we are working towards it.
Links
Company page · Results tracker
Anand Ganapathy K | SEBI Registered Research Analyst | INH000016630.